Distributional impact of government outlays on the Australian Pharmaceutical Benefits Scheme in 2001-02

Economic Record

Volumn 80, Issue SPEC. ISS., 2004, Pages

  Harding, Ann ^a   Abello, Annie ^a   Brown, Laurie ^a   Phillips, Ben ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRESCRIBING; MODELING; SOCIAL POLICY; WELFARE PROVISION;

AUSTRALASIA; AUSTRALIA; EASTERN HEMISPHERE; WORLD;

EID: 7444265775     PISSN: 00130249     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1475-4932.2004.00187.x     Document Type: Article

References (18)

1. Abello, A., Brown, L., Walker, A. and Thurecht, T. (2003), An Economic Forecasting Microsimulation Model of the Australian Pharmaceutical Benefits Scheme. NATSEM Technical Paper no. 30. University of Canberra, Canberra, 72.
2. ABS (2000), 1998-99 Household Expenditure Survey Australia, Confidentialised Unit Record File (CURF) Technical Paper, ABS Catalogue No. 6544.0.30.001, Australian Bureau of Statistics, Canberra.
3. ABS (2001), Government Benefits, Taxes and Household Income, Australia, ABS Catalogue No. 6537.0, Australian Bureau of Statistics, Canberra.
4. Brown, L., Abello, A., Phillips, B. and Harding, A. (2004), Moving towards an improved micro-simulation model of the Australian Pharmaceutical Benefits Scheme. Australian Economic Review, 37 (1), 41-61.
5. Brown, L., Walker, A., Waters, A., Harding, A. and Thurecht, L. (2002), 'Funding of High Cost Biotechnology and Other Innovative Targeted Therapies under the Pharmaceutical Benefits Scheme', Position Paper, 27 February, National Centre for Social and Economic Modelling, University of Canberra.
6. Commonwealth of Australia (2002a), 2002-03 Budget Paper No. 1, Budget Strategy and Outlook 2002-03.
7. Commonwealth of Australia (2002b), 2002-03 Budget Paper No. 5, Intergenerational Report 2002-03. InfoAccess, Canberra.
8. Commonwealth Department of Health and Ageing (2003), Australian Statistics on Medicines 1999-2000, Publications Approval no. 3183 (PA7270). Commonwealth of Australia, Canberra.
9. Commonwealth Department of Health and Ageing (2001), About the PBS. [Cited 17 June, 2004.] Available from URL: http://www.health.gov.au/pbs/general/aboutus.htm
10. Harding, A. (1995), 'The social wage and income distribution: the impact of health, education and housing outlays in 1994'. Australian Economic Review, Third Quarter, 71-86.
11. Harding, A., Percival, R., Schofield, D. and Walker, A. (2002), 'The lifetime distributional impact of government health outlays'. Australian Economic Review, 35 (2), 363-79.
12. Johnson, D., Manning, I. and Hellwig, O. (1995), Trends in the Distribution of Cash Income and Non Cash Benefits: an Overview. Report to the Department of the Prime Minister and Cabinet. AGPS, Canberra.
13. OECD (2000), Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals, Labour Market and Social Policy Occasional Paper no. 40. OECD, Paris.
14. Percival, R. and Schofield, D. (1995), Modelling Australian Public Health Expenditure, STINMOD Technical Paper no. 8. National Centre for Social and Economic Modelling, University of Canberra, Canberra.
15. Schofield, D. (1998), Re-examining the Distribution of Health Benefits in Australia: Who Benefits from the Pharmaceutical Benefits Scheme? Discussion Paper no. 36. National Centre for Social and Economic Modelling. University of Canberra, Canberra.
16. Walker, A., Kelly, S., Harding, A. and Abello, A. (2003), 'Health and income in Australia', AMP-NATSEM Income and Wealth Report, March (4).
17. Walker, A., Percival, P. and Fischer, S. (1998), A Microsimulation Model of Australia's Pharmaceutical Benefits Scheme, Technical Paper no. 15. National Centre for Social and Economic Modelling. University of Canberra, Canberra.
18. Walker, A., Percival, P. and Harding, A. (2000), 'The impact of demographic and other changes on expenditure on pharmaceutical benefits in 2020 in Australia', in Mitton, L., Sutherland, H. and Weeks, M., (eds). Microsimulation Modelling for Policy Analysis: Challenges and Innovations. Cambridge University Press, UK, 149-71.